Skip to content
Artwork for Sounds of Science
ScienceTechnology

Sounds of Science

Charles River

Sounds of Science is a monthly podcast about beginnings: how a molecule becomes a drug, how a rodent elucidates a disease pathway, how a horseshoe crab morphs into an infection fighter. The podcast is produced by Eureka, the scientific blog of Charles River, a contract research organization for drug discovery and development. Tune in and begin the journey.

Play
  • 26 episodes
  • fortnightly
  • Avg 27 min
  • English
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
  • Tuesday · 27 min

    The Science of Sight: Can Gene Therapy Reverse Blindness?

    Vision loss has long been considered irreversible, but that assumption is rapidly changing. In this episode, Charles River experts Shiva Vasanth and Mark Vezina unpack the remarkable advances in ocular gene therapy, a field that is redefining what's possible for patients with inherited and degenerative eye diseases. With new therapies already reaching patients and a growing pipeline of clinical trials underway, the future of vision science is coming into focus. Discover the possibilities that could reshape the way we treat blindness for generations to come. Show Notes Toxicology Services | Charles River Ocular Toxicology | Charles River Ocular Irritation Testing | Charles River

  • November 3 · 27 min

    Cure NF with Jack: One Family’s Impact on Rare Disease Research

     When Jack Burke was diagnosed with neurofibromatosis (NF) at age two, his family was met with uncertainty and few treatment options. Nearly two decades later, that diagnosis has inspired a mission. In this episode of Sounds of Science, Jack and his parents, Beth and Jake Burke, share how their journey led to the creation of Cure NF with Jack, an organization that has raised more than $4 million to advance NF research and advocacy. They also discuss Jack’s unique perspective as both a patient advocate and a Charles River intern, where he's experiencing firsthand how science and innovation can help shape the future of human health.   Show Notes  CRISPR Cas9 Gene Editing | Charles River Gene Therapy Services | Charles River Rare Disease Research for Drug Development | Charles River Crusade to Cure Jack | Eureka How Rare Diseases are Driving Gene Therapy Research | Eureka Charles River Presents: Patient Advocates from World Congress Cure NF with Jack

    • Transcript
  • October 20 · 19 min

    The Science of Healthier Models in Animal Welfare Research

    Animal welfare has been a priority since the beginning of lab animal research. After hundreds of years of working alongside lab animals, there is still more to learn about how they like to live, how they prefer to be handled, and how to make them as comfortable as possible. I am joined by Carly O’Malley, 3Rs Scientist for Animal Welfare and Training at Charles River, to discuss her most research into keeping our models happy and healthy.

  • October 6 · 28 min

    Can Psychedelics Reset the Brain?

    Description/Summary: What if mental health treatment started with changing how the brain connects? In this episode of Sounds of Science, neuropharmacologist Dr. Allison Feduccia explains how psychedelic‑assisted therapies may quiet rigid brain patterns, open new pathways, and reshape how we treat depression, trauma, and addiction. Show Notes Psychedelic Studies | Charles River Preclinical MRI In Vitro Imaging Services | Charles River Preclinical Neuroscience CRO Services | Charles River

  • September 15 · 35 min

    Reading the EU Roadmap

    For this discussion we brought together experts Dr. Matthias Herzler and Dr. Hennicke Kamp from the German Federal Institute for Risk Assessment and Charles River’s Head of Regulatory Affairs Ira Koval to discuss the European Union’s Roadmap for phasing out animal testing for chemical safety assessments. What does the roadmap really say, and what will implementation look like? How can we balance the public’s call for action with their safety? Listen now to find out!

  • September 1 · 19 min

    Advancing Oncology Through Open Science

    What happens when cutting‑edge science meets one of the most devastating pediatric cancers? In this episode of Sounds of Science, Dr. Aled Edwards discusses how open, collaborative research is helping scientists confront rare and fatal childhood cancers like diffuse intrinsic pontine glioma, and what it means when a potential therapy moves closer to reaching children who urgently need it. Show Notes The Disruptors: Meet Aled Oncology In Vivo Imaging Solutions | Charles River Oncology CRO Services | Charles River Open Science: The Parallel Universe | Podcast A Deadly Brain Cancer in Children | Blog

  • August 4 · 16 min

    The YWHAG Ultra-Rare Mutation: A Family Hunts for Solutions

    When Andrew Miner’s son James was diagnosed with an ultra-rare YWHAG mutation, the path forward was anything but clear. In this compelling episode of Sounds of Science, Andrew shares his family’s journey, the inspiration behind founding the YWHAG Foundation, and how advancing research is creating new possibilities and renewed hope for families affected by rare diseases. www.ywhagfoundation.org. https://www.criver.com/eureka/ywhag-ultra-rare-mutation-family-hunts-solutions

  • July 21 · 13 min

    Laboratory Biosecurity for Exotic Viruses

    From hantavirus to Ebola to cyclosporiasis, it’s hard to escape the news about outbreaks of exotic viruses in people. How might these diseases impact or be transmitted by animals? In this episode, which airs July 21, Ken Henderson, PhD, DACLAM, an expert on keeping research mice and rats safe from outside threats, shares his insights into the most up-to-date research on biosecurity. Show Notes Pathogen Binder | Charles River Research Animal Diagnostic Services | Charles River Research Models and Services | Charles River

  • July 7 · 38 min

    From Cell Painting to Toxicology: Advancing Treatment for PACS2 Therapy

    What happens when parents refuse to accept a one percent chance? In this episode of Sounds of Science, Piotr and Gosia Kosla share how their daughter Lena’s ultra‑rare diagnosis sparked a global scientific effort, advancing a potential treatment from discovery to an active preclinical toxicology study in just two years. Show Notes General Toxicology | Charles River Preclinical GLP Toxicology Studies Painting a Picture of Hope to Treat PACS2 | Podcast PACS2 Research Foundation

  • June 16 · 21 min

    A New Era for FOXG1: The Race to First‑in‑Human Trials

    FOXG1 Research Foundation CEO Nasha Fitter returns to Sounds of Science with extraordinary updates: FDA Fast Track designation, IND clearance, and the first‑ever clinical trial for a FOX G1 gene therapy now within reach. In this episode, hear how science, community, and a mother’s determination are rewriting what’s possible. Show Notes Cell and Gene Therapy CDMO Solutions | Charles River Viral Vector Manufacturing \ Charles River AAV Production for Rare Disease Therapies: From Challenge to Solution | Webcast Rare Disease | Charles River Rare Disease Research for Drug Development | Charles River FOX G1: A Mom’s Mission | Podcast

  • June 2 · 25 min

    Norecopa: A Global 3Rs Research Database Resides in Norway

    The 3Rs of animal research (Replacement, Reduction, Refinement) are truly a global effort. One of the experts leading this effort is veterinarian Adrian Smith, Secretary of the Norwegian organization Norecopa. Along with Executive Director Global Animal Welfare and Training for Charles River Liz Nunamaker, they share the creation and growth of Norway's National Consensus Platform and Centre for furthering the 3Rs, and how even researchers outside of Norway like Nunamaker benefit from its work.

    • Transcript
  • May 5 · 36 min

    Pac-Man Chemistry: A Breakthrough in Treating Methamphetamine Overdose

    What if one shot could reverse a meth overdose? In this episode of Sounds of Science, we explore CS1103 - Clear Scientific's breakthrough therapy with FDA Fast Track status that works like Pac-Man to clear toxins fast. Could this change emergency medicine forever? Tune in to find out. Clear Scientific: Combatting Drug Overdose from Methamphetamine, Fentanyl, and Polydrug | Charles River Podcast IND-Enabling Studies | Charles River Small Molecule Drug Development | Charles River Safety Assessment | Charles River

  • April 21 · 22 min

    CEO Jim Foster Reflects on his Remarkable 50 years at Charles River

    We are joined by retiring CEO Jim Foster to discuss his 50 year career at Charles River. Through his decades in the industry, Foster has seen it all - from the shift toward new approach methodologies, through mergers and sales and public offerings, to shaping the future of Charles River's culture. Listen now to hear how it all started, how we got here, and where we are heading in the future.

    • Transcript
  • April 7 · 37 min

    Finding Hope in the Rare: Jane’s Story and the Fight for Mowat-Wilson Syndrome Research

    In this episode of Sounds of Science, Lauren and Matt Noonan share their powerful journey following their daughter Jane’s diagnosis with Mowat-Wilson Syndrome. From unexpected medical challenges to finding community and launching their own nonprofit, the OURS Foundation, they discuss how advocacy, collaboration, and emerging research are shaping new hope for families living with rare diseases. Charles River | ASO Development Charles River | ASO Screening Services Charles River | Rare Disease Charles River | Rare Disease Research for Drug Development Mowat Wilson Foundation

  • March 17 · 31 min

    From Research to Regulatory: The Career of Dr. Namandjé Bumpus

    I am joined by Charles River's newest Senior Vice President, Chief Scientific & Innovation Officer Dr. Namandjé Bumpus to discuss her amazing career. From hands on research as Professor and Director of the Department of Pharmacology and Molecular Sciences at Johns Hopkins University School of Medicine, to Chief Scientist and later Principal Deputy Commissioner at the US Food and Drug Administration, Dr. Bumpus has seen every angle of the industry. She joins me to discuss her research, the discipline she learned from her father's boxing gym, and her perspective on the industry today.

  • March 3 · 41 min

    Bringing Dialysis to Remote Regions: Chris Atwater and the Bridge of Life

    Patients who need kidney dialysis live all over the world - even in some of the remotest regions. They need updated equipment, trained healthcare staff, and lots of clean water. Chris Atwater, Director of Technical Operations at the nonprofit Bridge of Life, helps bring hope to these areas. He has traveled to six continents for his life's work, using skills he learned as a United States Marine and the education he acquired for this role. If you are interested in learning more about challenges facing dialysis patients in remote areas, check out this video we made about services in the Australian bush.

  • February 17 · 23 min

    Hope in Action: Fighting SPG50 and Beyond with Elpida Therapeutics

    When Terry Pirovolakis learned his son had an ultra-rare neurodegenerative disease, SPG50, he refused to accept “no options.” What started as a desperate search for hope became Elpida Therapeutics, a nonprofit driving gene therapy innovation for multiple rare diseases. In this episode, Terry shares the remarkable journey from diagnosis to clinical trials, the power of partnerships, and why urgency matters when every day counts. Show Notes From Mystery to Medicine: The Science Behind a Mother’s Search | Podcast Taking a Customized and Collaborative Approach to Therapeutic Development | Podcast Rare Disease Research for Drug Development | Charles River Rare Disease | Charles River Discovery | Charles River Beyond The Diagnosis

  • February 3 · 39 min

    Turning Hope Into Action: Fighting USP7-Related Diseases

    What happens when a rare disease diagnosis turns life upside down? In this episode of Sounds of Science, host Mary Parker sits down with Bo Bigelow, Amber Freed, and David Fischer to explore the breakthroughs, challenges, and human stories behind Hao-Fountain Syndrome. From a father’s fight for his daughter Tess to cutting-edge drug repurposing screens, discover how science, advocacy, and community are rewriting the future for families worldwide. Show Notes Rare Disease | Charles River Vital Science Podcast: Strength in Numbers Rare Disease Research for Drug Development Foundation for USP-7 Related Diseases Stronger Every Day Podcast

  • January 20 · 25 min

    Beyond The Diagnosis

    When Patricia Weltin’s daughters were diagnosed with Ehlers-Danlos Syndrome after years of uncertainty, she turned her frustration into a global movement. In this episode of Sounds of Science, Patricia shares the story behind Beyond the Diagnosis, a powerful art and advocacy initiative that uses portraiture to humanize rare diseases and inspire empathy in medical professionals, students, and communities around the world. From medical schools to courthouses and even Parisian galleries, the traveling exhibit is reshaping how we see children with rare diseases—not as diagnoses, but as vibrant individuals with stories worth telling. Tune in to hear how Patricia’s mission is bridging the gap between science and compassion, and how you can help carry it forward. Show Notes From Mystery to Medicine: The Science Behind a Mother’s Search | Podcast Taking a Customized and Collaborative Approach to Therapeutic Development | Podcast Rare Disease Research for Drug Development | Charles River Rare Disease | Charles River Discovery | Charles River Beyond The Diagnosis

  • January 6 · 22 min

    Planning For Potential Pandemics: The Coalition for Epidemic Preparedness Innovations

    As we all learned in 2020, getting ahead of the next major pandemic is a matter of global concern. For the Coalition for Epidemic Preparedness Innovations, or CEPI (cepi.net), it is their reason for existing. Joining me for this conversation are Valentina Bernasconi, Head of Laboratory Science for CEPI, and Marie-Eve Poupart, Lead Scientist In Charles River’s Immunology department. Together we discuss CEPI’s progress so far, how Charles River is contributing to the cause, and how we can plan for the unknown Disease X while simultaneously handling current outbreaks of deadly diseases like Ebola, Marburg, Nipah virus, Lassa Fever, and chikungunya.

Showing 1–20 of 26 episodes